Annual Reports in Medicinal Chemistry

Paperback Engels 2010 9780123809025
€ 172,25
Levertijd ongeveer 9 werkdagen
Gratis verzonden

Samenvatting

Annual Reports in Medicinal Chemistry provides timely and critical reviews of important topics in medicinal chemistry together with an emphasis on emerging topics in the biological sciences, which are expected to provide the basis for entirely new future therapies.

Specificaties

ISBN13:9780123809025
Taal:Engels
Bindwijze:Paperback
Aantal pagina's:648

Lezersrecensies

Wees de eerste die een lezersrecensie schrijft!

Inhoudsopgave

Section I: Central Nervous System Diseases – ROBICHAUD
  1. Voltage-Gated Calcium Channel Antagonists for the Central Nervous System
  2. James C. Barrow and Joseph L. Duffy
  3. Recent Developments in Glycine Transporter-1 Inhibitors
  4. Christopher L. Cioffi, Shuang Liu and Mark A.Wolf
  5. Modulators of Transient Receptor Potential Ion Channels
  6. Rajagopal Bakthavatchalam and S. David Kimball
  7. Defining Neuropharmacokinetic Parameters in CNS Drug Discovery to Determine Cross-species Pharmacologic Exposure-Response Relationships
  8. Christopher L. ShafferSection II: Cardiovascular and Metabolic Diseases - STAMFORD
  9. High Affinity Niacin Receptor GPR109A Agonists
  10. Hong C. Shen and Steven L. Colletti
  11. Recent Advances in Acetyl CoA Carboxylase (ACC) Inhibitors
  12. Matthew P. Bourbeau, John G. Allen, and Wei Gu
  13. Enzymatic Targets in the Triglyceride Synthesis Pathway
  14. Dmitry O. Koltun and Jeff Zablocki
  15. Inhibitors of HIF Prolyl Hydroxylases
  16. Michael H. Rabinowitz, Terrance D. Barrett, Mark D. Rosen, Hariharan VenkatesanSection III: Inflammation / Pulmonary / GI - BARRISH/Weinstein
  17. Opioid Receptor Antagonists for Gastrointestinal Dysfunction
  18. R. William Hipkin and Roland E. Dolle
  19. CFTR Modulators for the Treatment of Cystic Fibrosis
  20. Sabine Hadida, Frederick Van Goor and Peter D. J. Grootenhuis
  21. Targeting B-cells in inflammatory disease
  22. Kevin S. Currie
  23. Modulators of Toll-Like Receptor (TLR) Signaling
  24. Mark Spyvee, Lynn Hawkins, and Sally IshizakaSection IV: Oncology - McAlpine
  25. Janus Kinase 2 (JAK2) inhibitors for the treatment of myeloproliferative neoplasm (MPN)
  26. Ashok V. Purandare, Matthew V. Lorenzi and Louis J. Lombardo
  27. Development of poly(ADP-ribose)polymerase (PARP) inhibitors in oncology
  28. Philip Jones
  29. Epigenetic Targets and Cancer Drug Discovery
  30. Patrick M. Woster, Ph.DSection V: Infectious Diseases - Primeau
  31. HIV-1 Integrase Strand Transfer Inhibitors
  32. Brian A. Johns
  33. Recent Advances in Drug Discovery for Neglected Tropical Diseases Caused by Infective Kinetoplastid Parasites
  34. Robert T. Jacobs and Charles Ding
  35. Recent Advances in the Inhibition of Bacterial Fatty Acid Biosynthesis
  36. Vincent GeruszSection VI: Topics in Biology - LOWE
  37. Back to the Plaque: Emerging Studies That Re-Focus Attention on the Neuritic Plaque in Alzheimer’s Disease
  38. Dr. Robert B. Nelson
  39. Targeting Methyl Lysine
  40. Stephen V. Frye, Tom Heightman and Jian Jin
  41. Chemical Proteomic Technologies for Drug Target Identification
  42. Kieran F. Geoghegan and Douglas S. Johnson
  43. NIH Translational Programs for Assisting Pre-Clinical Drug Discovery and Development
  44. Raj N. MisraSection VII: Topics in Drug Design and Discovery - DESAI
  45. Role of Physicochemical Properties and Lipophilic Ligand Efficiency (LipE or LLE) in addressing Drug Safety Risks
  46. Martin P. Edwards and David A. Price
  47. Reducing the Risk of Drug Attrition Associated with Physicochemical Properties
  48. Paul D. Leeson and James R. Empfield
  49. Compound Collection Enhancement and Paradigms for High Throughput Screening - an Update
  50. Stevan W Djuric, Irini Akritopoulou-Zanze, Philip B Cox and Scott Galasinski
  51. The Role of Fluorine in the Discovery and Optimization of CNS Agents: Modulation of Drug-Like Properties
  52. Kevin J. Hodgetts, Kerry J. Combs, Amy M. Elder and Geraldine C. Harriman
  53. Patents in Drug Discovery: Case Studies, Examples, and Simple Steps Medicinal Chemists Can Take to Protect Hard-Won Intellectual Property
  54. Charles J. Andres, Jr. and Richard L. TreanorSection VIII: Trends and Perspectives
  55. To Market, To Market – 2009


Shridhar Hegde and Michelle Schmidt

Managementboek Top 100

€ 172,25
Levertijd ongeveer 9 werkdagen
Gratis verzonden

Rubrieken

    Personen

      Trefwoorden

        Artikelen

          Annual Reports in Medicinal Chemistry